Genetic analysis reveals ongoing HIV type 1 evolution in infected human placental trophoblast

AIDS Research and Human Retroviruses

Volumn 15, Issue 18, 1999, Pages 1673-1683

  Zachar, Vladimir ^a,b   Zacharova, Viera ^c   Fink, Trine ^a   Thomas, Robert A ^c   King, Benjamin R ^c   Ebbesen, Peter ^a   Jones, Theodore B ^d   Goustin, Anton S ^c  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b INSTITUTE OF VIROLOGY   (Slovakia)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HUTZEL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN; ZIDOVUDINE;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PLACENTA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TROPHOBLAST; UMBILICAL CORD BLOOD; VERTICAL TRANSMISSION; VIRUS ENVELOPE; VIRUS INFECTION;

EID: 0032787512     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299309711     Document Type: Article

References (66)

1. Byers RH Jr, Galdwell MB, Davis S, Gwinn M, and Lindegren ML: Projection of AIDS and HIV incidence among children born infected with HIV. Stat Med 1998;17:169-181.
2. Kotler DP: HIV in pregnancy. Gastroenterol Clin North Am 1998;27:269-280.
3. Report of a Consensus Workshop, Siena, Italy, January 17-18, 1992. Maternal factors involved in mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr 1992;5:1019-1029.
4. Centers for Disease Control and Prevention: Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. MMWR 1998;47:1-30.
5. Fowler MG and Mofenson L: Progress in prevention of perinatal HIV-1. Acta Paediatr Suppl 1997;421:97-103.
6. Simonds RJ, Steketee R, Nesheim S, Matheson P, Palumbo P, Alger L, Abrams EJ, Orloff S, Lindsay M, Bardeguez AD, Vink P, Byers R, and Rogers M: Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV. Perinatal AIDS Collaborative Transmission Studies. AIDS 1998;12:301-308.
7. The European Collaborative Study: Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe. Br J Obstet Gynaecol 1998;105:704-709.
8. UNAIDS: AIDS epidemic update. In: UNAIDS Joint United Nations Programme on HIV/AIDS. 1998, pp. 1-17. http://www. unaids.org/
9. European Collaborative Study: Children born to women with HIV-1 infection: Natural history and risk of transmission. Lancet 1991;337:253-260.
10. Rouzioux C, Costagliola D, Burgard M, Blanche S, Mayaux MJ, Griscelli C, and Valleron AJ: Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group. Am J Epidemiol 1995;142:1330-1337.
11. Backe E, Jimenez E, Unger M, Schafer A, Jauniaux E, and Vogel M: Demonstration of HIV-1 infected cells in human placenta by in situ hybridisation and immunostaining. J Clin Pathol 1992;45:871-874.
12. Backe E, Jimenez E, Unger M, Schafer A, Vocks-Hauck M, Grosch-Worner I, and Vogel M: Vertical human immunodeficiency virus transmission: A study of placental pathology in relation to maternal risk factors. Am J Perinatol 1994;11:326-330.
13. Chandwani S, Greco MA, Mittal K, Antoine C, Krasinski K, and Borkowsky W: Pathology and human immunodeficiency virus expression in placentas of seropositive women. J Infect Dis 1991;163:1134-1138.
14. De Andreis C, Simoni G, Rossella F, Castagna C, Pesenti E, Porta G, Colucci G, Giuntelli S, Pardi G, and Semprini AE: HIV-1 proviral DNA polymerase chain reaction detection in chorionic villi after exclusion of maternal contamination by variable number of tandem repeats analysis. AIDS 1996;10:711-715.
15. Faulk WP and Labarrere CA: HIV proteins in normal human placentae. Am J Reprod Immunol 1991;25:99-104.
16. Katz JM, Fox CH, Eglinton GS, Meyers WA III, and Queenan JT: Relationship between human immunodeficiency virus-1 RNA identification in placenta and perinatal transmission. J Perinatol 1997;17:119-124.
17. Lewis SH, Reynolds-Kohler C, Fox HE, and Nelson JA: HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses. Lancet 1990;335:565-568.
18. Martin AW, Brady K, Smith SI, DeCoste D, Page DV, Malpica A, Wolf B, and Neiman RS: Immunohistochemical localization of human immunodeficiency virus p24 antigen in placental tissue. Hum Pathol 1992;23:411-414.
19. Mattern CF, Murray K, Jensen A, Farzadegan H, Pang J, and Modlin JF: Localization of human immunodeficiency virus core antigen in term human placentas. Pediatrics 1992;89:207-209.
20. Lee BN, Ordonez N, Popek EJ, Lu JG, Helfgott A, Eriksen N, Hammill H, Kozinetz C, Doyle M, Kline M, Langston C, Shearer WT, and Reuben JM: Inflammatory cytokine expression is correlated with the level of human immunodeficiency virus (HIV) transcripts in HIV-infected placental trophoblastic cells. J Virol 1997;71:3628-3635.
21. Zachar V, Thomas RA, Jones T, and Goustin AS: Vertical transmission of HIV: Detection of proviral DNA in placental trophoblast. AIDS 1994;8:129-130.
22. Sheikh AU, Polliotti BM, and Miller RK: In situ PCR discriminates between infected and uninfected human placental explants after in vitro exposure to HIV-1. Trophoblast Res 1997;12:191-204.
23. Anderson VM, Bard E, Zevallos EA, and Gu J: HIV clearance in infants. Lancet 1996;347:1122-1123.
24. Reuben JM, Gonik B, Li S, Loo L, and Turpin J: Induction of cytokines in normal placental cells by the human immunodeficiency virus. Lymphokine Cytokine Res 1991;10:195-199.
25. Zachar V, Ebbesen P, Thomas RA, Zacharova V, and Goustin AS: Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication. J Gen Virol 1994;75:1461-1468.
26. Zachar V, Hager H, Koppelhus U, Zacharova V, Liu X, Bambra C, Goustin AS, and Ebbesen P: Elevated interferon-alpha in maternal and umbilical cord blood and in the placental trophoblast suggests natural protection against vertical transmission of HIV-1 in a Kenyan cohort. AIDS 1997;11:383-385.
27. Douglas GC and King BF: Isolation of pure villous cytotrophoblast from term human placenta using immunomagnetic microspheres. J Immunol Methods 1989;119:259-268.
28. Zachar V, Norskov-Lauritsen N, Juhl C, Spire B, Chermann JC, and Ebbesen P: Susceptibility of cultured human trophoblasts to infection with human immunodeficiency virus type 1. J Gen Virol 1991;72:1253-1260.
29. Scarlatti G, Leitner T, Halapi E, Wahlberg J, Marchisio P, Clerici-Schoeller MA, Wigzell H, Fenyö EM, Albert J, Uhlen M, et al.: Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. Proc Natl Acad Sci USA 1993;90:1721-1725.
30. Zachar V, Spire B, Hirsch I, Chermann JC, and Ebbesen P: Human transformed trophoblast-derived cells lacking CD4 receptor exhibit restricted permissiveness for human immunodeficiency virus type 1. J Virol 1991;65:2102-2107.
31. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, and Parmentier M: Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (London) 1996;382:722-725.
32. Thompson JD, Higgins DG, and Gibson TJ: CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
33. Felsenstein J: PHYLIP (Phylogeny Inference Package), version 3.572c. Department of Genetics, University of Washington, Seattle, Washington, 1995. [Distributed by the author]
34. Hein J: A new method that simultaneously aligns and reconstructs ancestral sequences for any number of homologous sequences, when the phylogeny is given. Mol Biol Evol 1989;6:649-668.
35. Dighe PK, Korber BT, and Foley BT: Global variation in the HIV-1 V3 region. In: HIV Sequence Database (Korber BT, Hahn B, Foley B, Mellors JW, Leitner T, Myers G, McCutchan F, and Kuiken C, eds.). Los Alamos National Laboratory, Los Alamos, New Mexico, 1997.
36. Louwagie J, Janssens W, Mascola J, Heyndrickx L, Hegerich P, van der Groen G, McCutchan FE, and Burke DS: Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol 1996;69:263-271.
37. Fouchier RA, Groenink M, Kootstra NA, Tersmette M, Huisman HG, Miedema F, and Schuitemaker H: Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 1992;6: 3183-3187.
38. Bawdon RE, Gravell M, Hamilton R, Sever J, Miller R, and Gibbs CJ: Studies on the placental transfer of cell-free human immunodeficiency virus and p24 antigen in an ex vivo human placental model. J Soc Gynecol Invest 1994;1:45-48.
39. Fowler MG: Update: Transmission of HIV-1 from mother to child. Curr Opin Obstet Gynecol 1997;9:343-348.
40. Mulder-Kampinga GA, Kuiken C, Dekker J, Scherpbier HJ, Boer K, and Goudsmit J: Genomic human immunodeficiency virus type 1 RNA variation in mother and child following intra-uterine virus transmission. J Gen Virol 1993;74:1747-1756.
41. Mulder-Kampinga GA, Simonon A, Kuiken CL, Dekker J, Scherpbier HJ, van de Perre P, Boer K, and Goudsmit J: Similarity in env and gag genes between genomic RNAs of human immunodeficiency virus type 1 (HIV-1) from mother and infant is unrelated to time of HIV-1 RNA positivity in the child. J Virol 1995;69: 2285-2296.
42. Backe E, Unger M, Jimenez E, Siegel G, Schafer A, and Vogel M: Fetal organs infected by HIV-1. AIDS 1993;7:896-897.
43. Brossard Y, Aubin JT, Mandelbrot L, Bignozzi C, Brand D, Chaput A, Roume J, Mulliez N, Mallet F, Agut H, et al.: Frequency of early in utero HIV-1 infection: A bind DNA polymerase chain reaction study on 100 fetal thymuses. AIDS 1995;9:359-366.
44. Courgnaud V, Laure F, Brossard A, Bignozzi C, Goudeau A, Barin F, and Brechot C: Frequent and early in utero HIV-1 infection. AIDS Res Hum Retroviruses 1991;7:337-341.
45. Ehrnst A, Lindgren S, Dictor M, Johansson B, Sonnerborg A, Czajkowski J, Sundin G, and Bohlin AB: HIV in pregnant women and their offspring: Evidence for late transmission. Lancet 1991; 338:203-207.
46. Mano H and Chermann JC: Fetal human immunodeficiency virus type 1 infection of different organs in the second trimester. AIDS Res Hum Retroviruses 1991;7:83-88.
47. Soeiro R, Rubinstein A, Rashbaum WK, and Lyman WD: Maternofetal transmission of AIDS: Frequency of human immunodeficiency virus type 1 nucleic acid sequences in human fetal DNA. J Infect Dis 1992;166:699-703.
48. Stoltenburg G, Schmidt S, Marzheuser S, Herbst H, Spiegel H, and Unger M: The central nervous system of infants born to HIV-positive mothers - neuropathology, immunohistochemistry in in situ hybridization. Verh Dtsch Ges Pathol 1991;75:191-194.
49. Amirhessami-Aghili N and Spector SA: Human immunodeficiency virus type 1 infection of human placenta: Potential route for fetal infection. J Virol 1991;65:2231-2236.
50. David FJ, Autran B, Tran HC, Menu E, Raphael M, Debre P, Hsi BL, Wegman TG, Barré-Sinoussi F, and Chaouat G: Human trophoblast cells express CD4 and are permissive for productive infection with HIV-1. Clin Exp Immunol 1992;88:10-16.
51. Douglas GC, Fry GN, Thirkill T, Holmes E, Hakim H, Jennings M, and King BF: Cell-mediated infection of human placental trophoblast with HIV in vitro. AIDS Res Hum Retroviruses 1991;7:735-740.
52. Esterman AL, Finlay TH, Lee JD, and Dancis J: Uptake of human immunodeficiency virus envelope protein gp120 by human trophoblast in culture. Am J Obstet Gynecol 1996;174:49-54.
53. Fazely F, Fry GN, Thirkill TL, Hakim H, King BF, and Douglas GC: Kinetics of HIV infection of human placental syncytiotrophoblast cultures: An ultrastructural and immunocytochemical study. AIDS Res Hum Retroviruses 1995;11:1023-1030.
54. Kilani RT, Chang LJ, Garcia-Lloret MI, Hemmings D, Winkler-Lowen B, and Guilbert LJ: Placental trophoblasts resist infection by multiple human immunodeficiency virus (HIV) type 1 variants even with cytomegalovirus coinfection but support HIV replication after provirus transfection. J Virol 1997;71:6359-6372.
55. Peuchmaur M, Delfraissy JF, Pons JC, Emilie D, Vazeux R, Rouzioux C, Brossard Y, and Papiernik E: HIV proteins absent from placentas of 75 HIV-1-positive women studied by immunohistochemistry. AIDS 1991;5:741-745.
56. Contopoulos-Ioannidis DG and Ioannidis JP: Maternal cell-free viremia in the natural history of perinatal HIV-1 transmission: a meta-analysis. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:126-135.
57. van't Wout AB, Kootstra NA, Mulder-Kampinga GA, Albrecht-van Lent N, Scherpbier HJ, Veenstra J, Boer K, Coutinho RA, Miedema F, and Schuitemaker H: Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest 1994;94: 2060-2067.
58. Wolinsky SM, Wike CM, Korber BT, Hutto C, Parks WP, Rosenblum LL, Kunstman KJ, Furtado MR, and Munoz JL: Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992;255:1134-1137.
59. Gras G, Beyssen V, Tranchot-Diallo J, Parnet-Mathieu F, Lasfargues G, Courpotin C, and Dormont D: Neutralizing antibodies and complement-mediated, antibody-dependent enhancement (C′-ADE) of human immunodeficiency virus infection in its vertical transmission. Am J Reprod Immunol 1998;39:381-386.
60. Mabondzo A, Narwa R, Roques P, Gras GS, Herve F, Parnet-Mathieu F, Lasfargues G, Courpotin C, and Dormont D: Lack of correlation between vertical transmission of HIV-1 and maternal antibody titers against autologous virus in human monocyte-derived macrophages. J Acquir Immune Defic Syndr Hum Retroviral 1998;17:92-94.
61. MacDonald KS, Embree J, Njenga S, Nagelkerke NJ, Ngatia I, Mohammed Z, Barber BH, Ndinya-Achola J, Bwayo J, and Plummer FA: Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 1998;177:551-556.
62. O'Shea S, Newell ML, Dunn DT, Garcia-Rodriguez MC, Bates I, Mullen J, Rostron T, Corbett K, Aiyer S, Butler K, Smith R, and Banatvala JE: Maternal viral load, CD4 cell count and vertical transmission of HIV-1. J Med Virol 1998;54:113-117.
63. Pancino G, Leste-Lasserre T, Burgard M, Costagliola D, Ivanoff S, Blanche S, Rouzioux C, and Sonigo P: Apparent enhancement of perinatal transmission of human immunodeficiency virus type 1 by high maternal anti-gp160 antibody titer. J Infect Dis 1998; 177:1737-1741.
64. St Louis ME, Kamenga M, Brown C, Nelson AM, Manzila T, Batter V, Behets F, Kabagabo U, Ryder RW, Oxtoby M, et al.: Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA 1993;269: 2853-2859.
65. Van Dyke RB, Korber BT, Popek E, Macken C, Widmayer SM, Bardeguez A, Hanson IC, Wiznia A, Luzuriaga K, Viscarello RR, and Wolinsky S: The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy. J Infect Dis 1999;179:319-328.
66. Smyth RJ, Yi Y, Singh A, and Collman RG: Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate. J Virol 1998;72: 4478-4484.